125 results on '"Avouac, Jérome"'
Search Results
2. Actualisation 2024 des recommandations de la Société française de rhumatologie pour le diagnostic et la prise en charge des personnes souffrant de polyarthrite rhumatoïde
3. Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis
4. Les CAR-T cells ont-elles leur place dans les pathologies inflammatoires et auto-immunes ?
5. Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
6. Risque cardiovasculaire chez les patients atteints de rhumatismes inflammatoires chroniques
7. Recommandations pour l’évaluation du risque de maladie cardiovasculaire et thromboembolique veineuse avant l’instauration d’une thérapie ciblée dans les rhumatismes inflammatoires chroniques
8. Teleconsultation in rheumatology: A literature review and opinion paper
9. The phenotype of mixed connective tissue disease patients having associated interstitial lung disease
10. Busting the myth of methotrexate chronic hepatotoxicity
11. Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases
12. Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthood
13. COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection
14. Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study
15. Quelle place pour les inhibiteurs de JAK en 2022 ?
16. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
17. Évaluation systématique de la réponse humorale contre le SARS-CoV-2 dans une cohorte française de 283 patients atteints d’un rhumatisme inflammatoire chronique
18. Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases
19. Influence de l’origine ethnique sur le phénotype de patients atteints de sclérodermie systémique en France
20. Infections ostéoarticulaires et traitements ciblés des rhumatismes inflammatoires
21. Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice
22. Erosive arthritis autoantibodies in systemic sclerosis
23. Revue des récents essais randomisés dans la sclérodermie systémique
24. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)
25. Cellules CAR-T : extension aux maladies auto-immunes en rhumatologie
26. An update on recent randomized clinical trials in systemic sclerosis
27. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
28. Ethnic influence on the phenotype of French patients with systemic sclerosis
29. Données récentes sur la prise en charge clinique de la sclérodermie systémique
30. Anticoagulation in Autoimmune Rheumatic Diseases
31. Pseudotumoral calcinosis in systemic sclerosis: Data from systematic literature review and case series from two referral centres
32. Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice
33. Systemic sclerosis: Recent insight in clinical management
34. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
35. Estrogens Counteract the Profibrotic Effects of TGF-β and their Inhibition Exacerbates Experimental Dermal Fibrosis
36. Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database
37. Granulocytes and monocytes apheresis for polyarthritis in a multimorbid patient
38. Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France
39. Persistent remission of severe rheumatoid arthritis associated with myelodysplastic syndrome upon treatment with lenalidomide
40. Tendons, Joints, and Bone
41. Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis
42. Targeting synovial neoangiogenesis in rheumatoid arthritis
43. Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years
44. Sensitive B-cell receptor repertoire analysis shows repopulation correlates with clinical response to rituximab in rheumatoid arthritis.
45. Response to comments on “The phenotype of mixed connective tissue disease patients having associated interstitial lung disease” by Chevalier K et al. and Shih PC
46. N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis
47. Intestin des connectivites et vascularites
48. Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
49. Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension
50. A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.